Ofatumumab: a novel treatment for severe systemic lupus erythematosus

Rheumatology (Oxford). 2015 Mar;54(3):559-60. doi: 10.1093/rheumatology/keu475. Epub 2014 Dec 24.

Authors

C Clare Thornton¹, Nicola Ambrose¹, Yiannis Ioannou²

Affiliations

¹ Department of Rheumatology and Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, UK.
² Department of Rheumatology and Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, UK. y.ioannou@ucl.ac.uk.

PMID: 25539826
DOI: 10.1093/rheumatology/keu475

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Antigens, CD20 / immunology
Female
Humans
Lupus Erythematosus, Systemic / drug therapy*
Severity of Illness Index*
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antigens, CD20
ofatumumab